Uncategorized

Lilly’s obesity pill heads for diabetes filing after heart risk trial

Published

3 days ago

on

Eli Lilly’s recently approved obesity pill Foundayo cut the risk of cardiovascular events like heart attack and stroke by 16% versus a form of insulin, new data show, and the company is planning to file …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version